DRIVE-SHIFT: Modest Weight Gain Observed Through Wk 144 After Switch to DOR/3TC/TDF in Virologically Suppressed Adults

July 6-10, 2020; Virtual
More than 2 years after the switch to DOR/3TC/TDF, adjusted mean weight gains ranged from 1.2-1.4 kg with no evident differences by sex, race, or ethnicity. The majority of patients (~ 70%) experienced < 5% weight gain at Week 144 of the study.
Format: Microsoft PowerPoint (.ppt)
File Size: 240 KB
Released: July 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Educational grant provided by:
Gilead Sciences
ViiV Healthcare
Merck Sharp & Dohme Corp.

Related Content

Clinical Care Options (CCO) expert faculty Dr. Brenda Crabtree Ramírez discusses how the COVID-19 pandemic has reduced access to HIV care in México

Brenda E. Crabtree Ramírez, MD Released: March 2, 2021

Download expert-authored CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
Released: March 2, 2021

Download CCO slides reviewing data and guidelines on management of heavily-treatment experienced patients with HIV experiencing treatment failure

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021

Expert commentary on managing a TB outbreak in a socially and medically complex population of patients living with HIV

Nicky Mehtani, MD, MPH Released: February 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue